Origene_Jan2021_ProperAntibodyDesignKeeps - 11
Proper Antibody Design Keeps Specificity In Mind
analysis steps-including characterization-as
technologies to enhance characterization, isolation,
accurately and efficiently as possible.
and purification of mAbs, " states Khimani. " The
" Currently, there is a high desire to combine
chromatographic and electrophoretic techniques
multiple tasks into one single method, as
have been combined with mass spectrometry with
researchers require both detailed information and
significant improvements to the sample preparation
faster results, " explains Shen. " Monoclonal antibody
requirements. "
characterization is complicated, and many tasks
are involved in the process. These usually require
Monoclonal antibody
labor-intensive sample preparations and time-con-
characterization is
suming analyses. It is desirable to have instruments
complicated, and many tasks
that provide reproducibility, robustness, and ease
of use. "
Walker has also observed this trend: " Monoclonal
are involved in the process.
These usually require
antibody characterization involves a diverse set
labor-intensive sample
of advanced analytical techniques, many of which
preparations and time-
require specialist equipment and training. As some
technologies are maturing, there has been a move
toward more automated sample preparation and
data analysis to reduce timelines.
consuming analyses. "
Maryann Shen, PhD, LCMS
global marketing program
manager, Agilent Technologies
" An example of this is with mass spectrometry,
where hardware and software are becoming more
Khimani cites automated capillary electropho-
user-friendly, reducing the time taken by specialist
resis-based separation technologies and advances
operators. There is still, however, some work to be
in assay development as examples of the work
done in this area so that relatively inexperienced
being done, explaining that they " have enabled
operators can access the technology. "
evaluation of mAb in native conformation. "
A productive dialectic:
characterization needs and
technological capabilities
" With continued development of next-generation technologies and tools, characterization of
mAb will continue to evolve, " he predicts. " It will
be a growing space for investigators within the
Biopharmaceutical industry demand for more
biopharma and biologics segments. " ●
detailed mAb characterization systems will continue
to be a major development driver. " The analytical
field has witnessed continued development of
GENengnews.com
| 11
http://www.GENengnews.com
Origene_Jan2021_ProperAntibodyDesignKeeps
Table of Contents for the Digital Edition of Origene_Jan2021_ProperAntibodyDesignKeeps
Contents
Origene_Jan2021_ProperAntibodyDesignKeeps - 1
Origene_Jan2021_ProperAntibodyDesignKeeps - 2
Origene_Jan2021_ProperAntibodyDesignKeeps - Contents
Origene_Jan2021_ProperAntibodyDesignKeeps - 4
Origene_Jan2021_ProperAntibodyDesignKeeps - 5
Origene_Jan2021_ProperAntibodyDesignKeeps - 6
Origene_Jan2021_ProperAntibodyDesignKeeps - 7
Origene_Jan2021_ProperAntibodyDesignKeeps - 8
Origene_Jan2021_ProperAntibodyDesignKeeps - 9
Origene_Jan2021_ProperAntibodyDesignKeeps - 10
Origene_Jan2021_ProperAntibodyDesignKeeps - 11
Origene_Jan2021_ProperAntibodyDesignKeeps - 12
Origene_Jan2021_ProperAntibodyDesignKeeps - 13
Origene_Jan2021_ProperAntibodyDesignKeeps - 14
Origene_Jan2021_ProperAntibodyDesignKeeps - 15
Origene_Jan2021_ProperAntibodyDesignKeeps - 16
Origene_Jan2021_ProperAntibodyDesignKeeps - 17
Origene_Jan2021_ProperAntibodyDesignKeeps - 18
Origene_Jan2021_ProperAntibodyDesignKeeps - 19
Origene_Jan2021_ProperAntibodyDesignKeeps - 20
Origene_Jan2021_ProperAntibodyDesignKeeps - 21
Origene_Jan2021_ProperAntibodyDesignKeeps - 22
Origene_Jan2021_ProperAntibodyDesignKeeps - 23
Origene_Jan2021_ProperAntibodyDesignKeeps - 24
Origene_Jan2021_ProperAntibodyDesignKeeps - 25
https://www.nxtbookmedia.com